D
Cullinan Therapeutics, Inc. CGEM
$9.07 $0.111.23% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 24.98% 27.12% 10.97% 7.87% 2.67%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 22.26% 3.29% 4.22% 11.27% 5.13%
Operating Income -22.26% -3.29% -4.22% -11.27% -5.13%
Income Before Tax -20.35% 1.04% -0.71% -7.85% -218.14%
Income Tax Expenses 100.83% 100.83% -660.06% -222.35% -122.89%
Earnings from Continuing Operations -33.09% -8.04% 7.11% -1.25% -310.02%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -100.00% -90.10% 302.47% 241.86% 39.03%
Net Income -35.05% -9.28% 8.07% -0.28% -302.52%
EBIT -22.26% -3.29% -4.22% -11.27% -5.13%
EBITDA -22.31% -3.30% -4.22% -11.23% -5.04%
EPS Basic 1.51% 15.34% 22.90% 7.74% -333.93%
Normalized Basic EPS 9.96% 21.66% 16.30% 2.85% -0.01%
EPS Diluted 1.51% 15.34% 22.94% 7.80% -358.90%
Normalized Diluted EPS 9.96% 21.66% 16.30% 2.85% -0.72%
Average Basic Shares Outstanding 37.02% 29.38% 17.78% 6.74% -4.76%
Average Diluted Shares Outstanding 37.02% 29.38% 17.78% 6.74% -5.57%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --